BeOne Medicines
ONC
#832
Rank
$29.87 B
Marketcap
$287.92
Share price
-0.92%
Change (1 day)
17.24%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Half-year Reports

Thumbnail BeOne Medicines Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report